Keyphrases
Warfarin
100%
Recurrence Risk
100%
Secondary Prevention
100%
Rivaroxaban
100%
Direct Oral Anticoagulants
100%
Venous Thrombosis
100%
Thrombosis Recurrence
100%
Apixaban
71%
Confidence Interval
71%
Hazard Ratio
71%
Recurrent Venous Thromboembolism
71%
Hospitalization
57%
Venous Thromboembolism
42%
Kidney Disease
28%
Venous Thromboembolism Prevention
28%
Anticoagulation
28%
Risk Reduction
14%
Renal Function
14%
Kidney Function
14%
Hospitalization Rate
14%
Low Risk
14%
Treatment Duration
14%
Retrospective Cohort Study
14%
Relative Rate
14%
MarketScan
14%
Oral Anticoagulation
14%
Propensity Score
14%
Diverse Patient Population
14%
Insurance Database
14%
Pharmacology, Toxicology and Pharmaceutical Science
Direct Oral Anticoagulant
100%
Venous Thromboembolism
100%
Vein Thrombosis
100%
Recurrence Risk
100%
Warfarin
100%
Rivaroxaban
70%
Apixaban
50%
Kidney Disease
20%
Cohort Study
10%